---
document_datetime: 2025-05-05 14:17:04
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ketoconazole-esteve-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: ketoconazole-esteve-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.1113509
conversion_datetime: 2025-12-25 04:05:12.598516
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ketoconazole Esteve

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number      | Scope                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|-------------------------|-------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Marketing Authorisation | - Transfer of a marketing authorisation - | 17/02/2025                          | 04/04/2025                                  | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Transfer - H / EMA/T/0000248405   | transfer of marketing authorisation from Esteve RD France S.A.S. to Esteve Pharmaceuticals S.A.   | Labelling and PL   |
|-----------------------------------|---------------------------------------------------------------------------------------------------|--------------------|